GLP-1 medications are changing lives. But the science is clear: without resistance training, you’re losing more than just weight.
HEALTH & WELLNESS · MARCH 2026
If you’re taking a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, you already know the appeal. The weight comes off. The cravings quiet down. You feel like the deck is finally stacked in your favor. And it is — these are genuinely remarkable drugs.
But here’s something your prescribing doctor may not have had time to spell out: the weight you’re losing isn’t all fat. A meaningful chunk of it is muscle. And over time, if you don’t do something to protect your lean mass, you could end up lighter on the scale but weaker, more fragile, and at higher risk for serious health problems down the road.
The good news? The fix doesn’t require hours at the gym. In fact, it fits perfectly into the “microdose workout” approach — short bursts of resistance movement, done consistently. Here’s what the science says.
The Hidden Cost of GLP-1 Weight Loss
Studies on semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) consistently find that 25% to 40% of the weight lost on these drugs is lean body mass — which includes muscle. The landmark STEP 1 trial of semaglutide found that roughly 40% of total weight lost came from lean tissue, not fat. That’s not nothing.
25–40%
of GLP-1 weight loss can come from lean muscle mass, not fat
30%
higher osteoporosis risk in GLP-1 users vs. non-users (new AAOS research)
~1 in 8
U.S. adults are now taking a GLP-1 medication
10 min
of daily resistance training can meaningfully preserve muscle and bone
Why does this matter? Muscle is metabolically active tissue. It burns calories at rest, regulates blood sugar, protects your joints, and keeps your bones dense. Losing it makes you more prone to fatigue, injury, and the kind of age-related frailty that is very hard to reverse.
New Research: GLP-1s and Bone Risk
A March 2026 study presented at the American Academy of Orthopaedic Surgeons found that GLP-1 users had approximately 30% higher rates of osteoporosis compared to non-users. As GLP-1 drugs reduce appetite — and therefore nutrient intake — bones can lose density along with bodyweight. Exercise is one of the most evidence-based tools we have to counteract this.
Why Resistance Training Is Non-Negotiable
Exercise — especially resistance or weight-bearing exercise — is the most proven way to preserve muscle and bone during weight loss. A landmark 2024 randomized clinical trial published in JAMA Network Open followed 195 adults with obesity for 52 weeks. It found that people who combined GLP-1 therapy with exercise maintained significantly better bone mineral density at the hip, spine, and forearm than people who used GLP-1 therapy alone.
“It would seem highly advisable to implement targeted physical exercise to preserve and potentially enhance muscle mass in patients receiving GLP-1 based therapies.”
— Frontiers in Endocrinology, 2024
A separate case series published in PMC showed that GLP-1 users who did structured resistance training 3–5 days per week didn’t just preserve muscle — two out of three patients actually increased their lean mass while losing significant body fat. That’s the difference between losing weight and genuinely transforming your body composition.
The bottom line from the research: the drug does the fat loss. You do the muscle saving.
This Is Where Microdose Workouts Come In
Here’s the thing about people on GLP-1 medications: they’re often looking for the most effective, least effortful path. That’s not a criticism — it’s smart. These drugs work precisely because they lower the threshold for success. Microdose workouts follow the same philosophy.
You don’t need a 60-minute gym session to protect your muscle mass. Research shows that short, frequent bouts of resistance exercise — even as little as 5 to 10 minutes at a time — stimulate the muscle-preserving response your body needs. A 2025 study from Edith Cowan University found that a daily 5-minute bodyweight workout helped improve strength, flexibility, and mood even in people who rarely exercise.
“People taking GLP-1 medications already have a shortcut for appetite and fat loss. Microdose resistance training is the shortcut for keeping the muscle.”
— Certified Strength & Conditioning Specialist
Think of it as pairing two efficiency tools: the drug handles caloric reduction; the short daily workout handles muscle and bone preservation. Together, they produce a result that neither can achieve alone.
What This Can Look Like in Your Day
10 Microdose Cardio Ideas for Non-Cardio People (Each 1–10 Minutes)
- Wall push-ups or floor push-ups (3 sets of 10–15 reps) while coffee brews
- Bodyweight squats or chair squats — great for quads, glutes, and bone density
- Resistance band rows or curls at your desk or in front of the TV
- Stair climbing at a brisk pace — one of the most studied bone-protective activities
- Slow, controlled lunges while on a phone call
- Plank holds (20–30 seconds) — builds core strength without requiring a gym
- Heel raises while standing at the kitchen counter — protects ankle and calf muscle
You don’t need weights. You don’t need a gym membership. You need consistency and a little bit of effort applied in the right direction. Even three or four of these “microdoses” per week can make a meaningful difference to your muscle and bone health over time.
The Takeaway
GLP-1 medications are a powerful tool. But tools work best when used correctly. The research is unambiguous: without some form of resistance exercise, you risk losing the muscle and bone density you need for a long, healthy life. And with microdose workouts, the bar couldn’t be lower.
Ten minutes. A few times a week. No gym required. Just like your medication asks very little of you each week for a big reward, so does this.
The scale is only telling you part of the story. Make sure the rest of the story is a good one.
The Studies Behind This Article
- Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment (JAMA Network Open, 2024) — RCT of 195 adults over 52 weeks. Exercise + GLP-1 therapy preserved bone density at the hip, spine, and forearm vs. GLP-1 therapy alone, which led to reduced bone mineral density.
- Preservation of Lean Soft Tissue During Weight Loss with GLP-1 Therapies (PMC, 2025) — Case series showing GLP-1 users who combined resistance training (3–5 days/week) with adequate protein either minimized muscle loss or actually increased lean soft tissue while losing fat.
- GLP-1s May Increase Risk of Osteoporosis, New Research Finds (AAOS / NBC News, 2026) — Large retrospective study presented at the American Academy of Orthopaedic Surgeons found GLP-1 users had approximately 30% higher rates of osteoporosis and nearly double the risk of bone mineral density issues over five years.
- Muscle Mass and GLP-1 Receptor Agonists: Adaptive or Maladaptive Response? (Circulation, 2024) — Comprehensive review from the American Heart Association journal. Semaglutide associated with lean mass loss of up to 40% of total weight lost in the STEP 1 trial; underscores the importance of targeted lifestyle interventions.
- GLP-1s and Lean Mass: What the Research Shows (ACE Fitness, 2025) — Analysis of a genetic study of 800,000+ individuals confirming that while GLP-1s reduce both fat and lean mass, fat loss is more substantial. Recommends resistance training 2–3x per week and protein targets of 1.2–1.6g/kg/day to preserve muscle.
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or care team before changing your exercise routine while on any medication.
